Laura L. Licato
- Molecular Biology
- Hepatology top 5%
- Immunology
- Cancer Research top 10%
- Epidemiology
- Co-authors
- David A. BrennerChristian JobinClaus HellerbrandR. Balfour SartorBalfour R. SartorYuji IimuroElizabeth A. GrimmKonrad L. Streetz
- Topics
- NF-κB Signaling Pathways (4 papers)Virus-based gene therapy research (2 papers)Liver physiology and pathology (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Laura L. Licato
13 papers receiving 777 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 284
- Hepatology 190
- Immunology 188
- Cancer Research 183
- Epidemiology 163
Countries citing papers authored by Laura L. Licato
This map shows the geographic impact of Laura L. Licato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Licato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Licato more than expected).
Fields of papers citing papers by Laura L. Licato
This network shows the impact of papers produced by Laura L. Licato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Licato. The network helps show where Laura L. Licato may publish in the future.
Co-authorship network of co-authors of Laura L. Licato
This figure shows the co-authorship network connecting the top 25 collaborators of Laura L. Licato. A scholar is included among the top collaborators of Laura L. Licato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura L. Licato. Laura L. Licato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 54 | |
| 3 | Tumor p53 biomarkers personalize selection of adenoviral p53 gene therapy or methotrexate as potentially efficacious treatments in different and complementary groups of recurrent squamous cell carcinoma of the head and neck (SCCHN) | 1 |
| 4 | 44 | |
| 5 | 16 | |
| 6 | 74 | |
| 7 | 50 | |
| 8 | 33 | |
| 9 | 101 | |
| 10 | 47 | |
| 11 | 155 | |
| 12 | 87 | |
| 13 | 131 | |
| 14 | 1 |
About Laura L. Licato
Laura L. Licato is a scholar working on Otorhinolaryngology, Cancer Research and Hepatology, having authored 14 papers that have together received 794 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (4 papers), Virus-based gene therapy research (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Hepatology (190 citations), Cancer Research (183 citations) and Pharmacology (98 citations). Laura L. Licato has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include David A. Brenner, Christian Jobin, Claus Hellerbrand, R. Balfour Sartor, Balfour R. Sartor, Yuji Iimuro, Elizabeth A. Grimm, Konrad L. Streetz, Michael P. Manns and Gisa Tiegs. Their work appears in journals such as Journal of Biological Chemistry, Nature Biotechnology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.